This review focuses on the liver circadian clock as relevant to the risk of developing metabolic diseases including nonalcoholic fatty liver disease (NAFLD), insulin resistance, and type 2 diabetes (T2D). This evidence concerns the gene CLOCK and metabolic dysfunction-associated steatotic liver disease.